Pancreatic Cancer Research

Clinical trialObsRecruiting

Prediction of Neoadjuvant Chemotherapy Response in Pancreatic Cancer

An Exosomal miRNA Based Predictive Model for Personalized Neoadjuvant Chemotherapy Selection in Pancreatic Ductal Adenocarcinoma

NCT07226154↗ ClinicalTrials.gov, retrieved 4 November 2026

Outcome
Ongoing
Phase
Obs
Status
Recruiting
Study type
Observational
Start
15 November 2024
Expected end
1 December 2026
Enrollment
200 participants
Sites
1
Primary outcomes
Pathological Response Rate
Sponsor
Other
Results posted
No
Last update
19 August 2026

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Papers 11